Tim Watts, CFO at Shield Therapeutics #STX presenting at our Life Sciences Investor Briefing Watch Now

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price: 1,671.60
Bid: 1,659.20
Ask: 1,660.20
Change: 13.80 (0.83%)
Spread: 1.00 (0.06%)
Open: 1,649.20
High: 1,678.20
Low: 1,646.40
Yest. Close: 1,657.80
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

EXTRA: GlaxoSmithKline Acquires US Oncology Firm, Sells Horlicks Unit

LONDON (Alliance News) - GlaxoSmithKline PLC on Monday announced it will pay USD5.1 billion for oncology-focused US pharma company Tesaro Inc and sell its Indian nutrition brands to Unilever FTSE

3 Dec 18 13:26

TOP NEWS: GSK To Buy US Biopharma Company Tesaro For USD5 Billion

LONDON (Alliance News) - GlaxoSmithKline PLC said Monday it will acquire oncology-focused US pharma business Tesaro Inc for USD5.1 billion in cash.Tesaro is a commercial-stage biopharma and

3 Dec 18 12:40

GlaxoSmithKline to buy oncology-focused Tesaro for $5.1bn

(Sharecast News) - GlaxoSmithKline has agreed to buy US-based oncology-focused pharmaceutical group Tesaro Inc for around $5.1bn (£4bn).

3 Dec 18 12:08

Unilever agrees £3.1bn Horlicks deal with GSK

(Sharecast News) - Unilever has struck a deal to buy Horlicks and other nutrition brands listed in India and Bangladesh from GlaxoSmithKline for roughly £3.1bn.

3 Dec 18 08:41

TOP NEWS: Glaxo Confirms Merger Talks For Indian Nutrition Business

LONDON (Alliance News) - GlaxoSmithKline PLC on Thursday confirmed that it is considering a merger transaction for its Horlicks nutritional drinks brand and other consumer healthcare nutrition did

29 Nov 18 12:23

GSK says no decision yet made on Horlicks business

(Sharecast News) - Following reports that it was close to selling its Indian Horlicks business, GlaxoSmithKline on Thursday said only that it is considering a deal.

29 Nov 18 11:52

Unilever close to buying GSK's Horlicks business - report

(Sharecast News) - Unilever is in pole position to guzzle up GlaxoSmithKline's Indian Horlicks business and associated nutrition brands for around $4bn, according to reports.

28 Nov 18 08:35

Manchester & London Investment Trust Ahead Of Benchmark In Full Year

LONDON (Alliance News) - Manchester & London Investment Trust PLC on Friday upped its dividend by a third as it outperformed its benchmark in its recently ended financial year.In &

23 Nov 18 11:19

TOP NEWS: GSK Signs Anaemia Drug Distribution Deal With Japanese Firm

LONDON (Alliance News) - GlaxoSmithKline PLC said Thursday it has signed a strategic commercialisation deal for its anaemia drug Daprodustat with Japanese firm Hakko Kirin Co Ltd.Financial

22 Nov 18 08:33

EXTRA: Glaxo Tightens Outlook To Upper End Of Estimates On Shingrix

LONDON (Alliance News) - GlaxoSmithKline PLC on Wednesday posted a flat third quarter pretax profit and tightened annual outlook to upper end of its estimates due to higher than expected sales of

31 Oct 18 15:42

TOP NEWS: Glaxo Tightens Annual Outlook To Upper End Of Estimates

LONDON (Alliance News) - GlaxoSmithKline PLC on Wednesday posted a flat third quarter profit and tightened annual outlook to upper end of its estimates on continuation of strong trading in Glaxo a

31 Oct 18 12:42

GSK tightens guidance as new shingles drug boosts earnings

(Sharecast News) - GlaxoSmithKline tightened up its full year guidance after a strong launch for its new Shingrix shingles vaccine helped the drug maker to a stronger than expected third quarter.

31 Oct 18 12:27

Wednesday preview: BoJ, GlaxoSmithKline and Next in the spotlight

(Sharecast News) - Barring surprises, the focus on Wednesday will likely be on the Bank of Japan's monetary policy meeting, with traders scanning the headlines for any whiff of any potential near-term shifts in its policy settings.

30 Oct 18 16:23

Glaxo Reports Positive Data For ViiV Healthcare's FLAIR HIV Study

LONDON (Alliance News) - GlaxoSmithKline PLC said Tuesday that ViiV Healthcare's FLAIR study met its primary endpoint, reporting "positive headline results".ViiV is a HIV by -

30 Oct 18 15:02

GlaxoSmithKline reports encouraging results from HIV drug trial

(Sharecast News) - Blue chip GlaxoSmithKline said a study into a new HIV drug regime, which could dramatically reduce the number of annual doses required, had been "encouraging".

29 Oct 18 10:51

Login to your account

Don't have an account? Click here to register.